Growth is vital to the success of every business. We created Growthsurance™ as a means of enabling revenue growth and reducing the risk of not achieving your business targets. Fresh and innovative, Growthsurance™ can help to increase market share, reduce the risk your business plan is exposed to, and protect earnings. Growthsurance™ can even support a loyalty scheme or promote sales campaigns.
Growthsurance™ helps create and protect business opportunities for our clients. We help you identify insurance-related opportunities as well as threats to your business plan and then develop innovative solutions to protect it.
Our new insurance approach is as flexible as it is innovative. Growthsurance™ is an idea-driven insurance solution that lends itself to an almost limitless number of possibilities. We provide protection to help you insure against many risks such as lost income due to "black swan" events or the financial impact of regulatory actions. We can also help you develop business opportunities, such as building customer loyalty schemes.
We partner flexibility with reliability. As part of Swiss Re, we provide unsurpassed coverage and a high level of financial security, with a Standard & Poor's 'AA-' rating. We also provide world-class underwriting skills and a claims process that is transparent, accountable and above all, efficient.
Contact us to learn more.
The AIRMIC Conference has become the most important event in the calendar for the insurance and risk management industry. The whole industry comes together to share experiences and influence forward thinking. The conference provides a vibrant platform for Swiss Re Corporate Solutions to highlight our broad, global commercial insurance offerings.Learn more
By the age of 65, it is estimated that 75% of physicians in low-risk specialties and 99% in high-risk specialties will have experienced a lawsuit. OB/GYNS are among the most likely to be sued among all physicians. Keeping pace with obstetrics patient safety science and risk mitigation strategies is challenging yet essential for promoting the best clinical outcomes.Learn more
30 January 2018
29 November 2017